Avacta Group PLC | Cash Flow

Fiscal year is August-July. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
1,521.00
1,470.00
4,893.00
4,647.00
6,367.00
8,829
Depreciation, Depletion & Amortization
367.00
527.00
576.00
1,246.00
1,583.00
2,034
Other Funds
312.00
52.00
1,759.00
456.00
616.00
991
Funds from Operations
842.00
891.00
2,558.00
3,857.00
4,168.00
5,804
Changes in Working Capital
535.00
53.00
43.00
376.00
73.00
336
Net Operating Cash Flow
1,377.00
838.00
2,515.00
4,233.00
4,241.00
5,468
Capital Expenditures
2,233.00
2,800.00
3,866.00
4,625.00
2,128.00
Sale of Fixed Assets & Businesses
-
-
2,210.00
-
-
Purchase/Sale of Investments
-
-
-
10,000.00
6,000.00
Net Investing Cash Flow
2,233.00
2,800.00
1,656.00
14,625.00
3,872.00
Net Financing Cash Flow
1.00
14,536.00
21.00
21,049.00
14.00
Net Change in Cash
3,609.00
10,898.00
4,150.00
2,191.00
355.00
Free Cash Flow
1,855.00
1,760.00
3,321.00
7,096.00
4,899.00
Change in Capital Stock
1.00
14,536.00
21.00
21,049.00
14.00

About Avacta Group

View Profile
Address
Thorp Arch Estate
Leeds West Yorkshire LS23 7FA
United Kingdom
Employees -
Website http://avacta.com
Updated 07/08/2019
Avacta Group Plc engages in the provision of proprietary solutions to the healthcare sector. It operates through the Life Sciences and Animal Health segments. The Life Sciences segment offers custom Affimers for reagents and diagnostics, drug and biomarker discovery in biotech research and development.